Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: Systematic literature review and meta-analysis

Influenza and other Respiratory Viruses

Volumn 12, Issue 1, 2018, Pages 22-29

  Coleman, Brenda L ^a   Fadel, Shaza A ^a   Fitzpatrick, Tiffany ^a   Thomas, Sera Melisa ^a  

^a University of Toronto   (Canada)

Author keywords

hospitalization; income; influenza; mortality; risk factors

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; ASTHMA; COMPARATIVE STUDY; DISEASE ASSOCIATION; HEALTH SERVICE; HELP SEEKING BEHAVIOR; HEMATOLOGIC DISEASE; HIGH INCOME COUNTRY; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLUENZA; INTENSIVE CARE; LABORATORY TEST; LIVER DISEASE; LOW INCOME COUNTRY; MIDDLE INCOME COUNTRY; MORBIDITY; MORTALITY; NEUROLOGIC DISEASE; OBESITY; PREDICTOR VARIABLE; PREGNANT WOMAN; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; COMPLICATION; DEVELOPING COUNTRY; ECONOMICS; INCOME; META ANALYSIS; POVERTY;

DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; HUMANS; INCOME; INFLUENZA, HUMAN; POVERTY; RISK FACTORS;

EID: 85036523123     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/irv.12504     Document Type: Article

References (60)

1. World Health Organization. Influenza (seasonal) Geneva, CH2014 [updated 2014, Mar; cited 2014]. Fact Sheet #211:[Available from: http://www.who.int/mediacentre/factsheets/fs211/en/.
2. Siddhivinayak H. Seasonal influenza vaccine use in low and middle income countries in the tropics and subtropics: a systematic review 2015. Available from: http://apps.who.int/iris/bitstream/10665/188785/1/9789241565097_eng.pdf.
3. Grohskopf LA, Sokolow LZ, Olsen SJ, Bresee JS, Broder KR, Karron RA. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices, United States, 2015-16 influenza season. MMWR Morb Mortal Wkly Rep. 2015;64:818-825. Epub 2015/08/08 PubMed PMID: 26247435.
4. European Centre for Disease Prevention and Control. Influenza vaccination Solna, SE: ECDC; 2015 [cited 2016]. Available from: http://ecdc.europa.eu/en/healthtopics/seasonal_influenza/vaccines/Pages/influenza_vaccination.aspx.
5. National Advisory Committee on Immunization. National Advisory Committee on Immunization (NACI): Canadian Immunization Guide chapter on influenza and statement on seasonal influenza vaccine for 2015–2016 update. Ottawa, ON: Public Health Agency of Canada; 2015:61.
6. Dwyer D, Barr I, Hurt A, et al. Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region. Western Pac Surveill Response J. 2013;4:51-59. Epub 2013/12/10. https://doi.org/10.5365/wpsar.2013.4.1.009. PubMed PMID: 24319615; PubMed Central PMCID: PMCPMC3851365.
7. Australian Technical Advisory Group on Immunization. Australian Technical Advisory Group on Immunisation (ATAGI) advice for immunisation providers regarding the administration of seasonal influenza vaccines in 2016 Australia: Australian Government Department of Health; 2016. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/ATAGI-advice-influenza-vaccines-providers.
8. Coleman BL, Fadel SA, Fitzpatrick T, Thomas S-M. Risk factors for seasonal influenza disease with severe outcomes. PROSPERO: International prospective register of systematic reviews [Internet]. 2016. Available from: https://www.crd.york.ac.uk/PROSPERO/.
9. The World Bank. World bank country and lending groups Washington, DC, USA, 2015 [cited 2016 2016-Mar-15]. Available from: http://data.worldbank.org/about/country-and-lending-groups.
10. Systran International. Systran 7 Translator Professional. Seoul, South Korea: Systran International; 2015.
11. Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, CA: The Ottawa Hospital Research Institute; 2014 [cited 2015]. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
12. Anon. Newcastle-Ottawa scale adapted for cross-sectional studies. unk.
13. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269. https://doi.org/10.7326/0003-4819-151-4-200908180-00135.
14. StataCorp. Stata statistics/data analysis. 14.2 edn. College Station, Texas: StataCorp LP; 2017.
15. Puvanalingam A, Rajendiran C, Sivasubramanian K, Ragunanthanan S, Suresh S, Gopalakrishnan S. Case series study of the clinical profile of H1N1 swine flu influenza. J Assoc Physicians India. 2011;59:8. PubMed PMID: 21751659.
16. Gonzalez-Candelas F, Astray J, Alonso J, et al. Sociodemographic factors and clinical conditions associated to hospitalization in influenza a (H1N1) 2009 virus infected patients in Spain, 2009-2010. PLoS ONE. 2012;7:e33139. https://doi.org/10.1371/journal.pone.0033139. PubMed PMID: 2012133027.
17. Cohen C, Moyes J, Tempia S, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013;19:1766-1774. https://doi.org/10.3201/eid1911.130546. PubMed PMID: 2013693593.
18. Gonzalez R, Balasso V, Uriona S, et al. Patient characteristics and health care burden during the influenza A (H1N1) 2009 pandemic in the university Hospital Vall d'Hebron of Barcelona. Enferm Infecc Microbiol Clin. 2011;29:593-600. https://doi.org/10.1016/j.eimc.2011.05.005. PubMed PMID: 2011526364.
19. Lynfield R, Davey R, Dwyer DE, et al. Outcomes of influenza A(H1N1)pdm09 virus infection: results from two international cohort studies. PLoS ONE. 2014;9:e101785. https://doi.org/10.1371/journal.pone.0101785. PubMed PMID: 2014457023.
20. Ward KA, Spokes PJ, McAnulty JM. Case-control study of risk factors for hospitalization caused by pandemic (H1N1) 2009. Emerg Infect Dis. 2011;17:1409-1416. https://doi.org/10.3201/eid1708.100842. PubMed PMID: 2011415680.
21. Kwan-Gett TS, Baer A, Duchin JS. Spring 2009 H1N1 influenza outbreak in King County, Washington. Dis Med Public Health Prep. 2009;3:S109-S116. https://doi.org/10.1097/DMP.0b013e3181c6b818.PubMedPMID:WOS:000274440700006.
22. Ren YY, Yin YY, Li WQ, et al. Risk factors associated with severe manifestations of 2009 pandemic influenza A (H1N1) infection in China: a case-control study. Virol J. 2013;10:149. https://doi.org/10.1186/1743-422x-10-149. PubMed PMID: 2013326108.
23. Wie SH, So BH, Song JY, et al. A comparison of the clinical and epidemiological characteristics of adult patients with laboratory-confirmed influenza A or B during the 2011-2012 influenza season in Korea: A multi-center study. PLoS ONE. 2013;8:e62685. https://doi.org/10.1371/journal.pone.0062685. PubMed PMID: 2013284450.
24. Lee MC, Kim HY, Kong SG, et al. Clinical characteristics of pandemic influenza A (H1N1) 2009 pediatric infection in Busan and Gyeongsangnam-do: One institution. Tuberc Respir Dis. 2012;72:493-500. https://doi.org/10.4046/trd.2012.72.6.493. PubMed PMID: 2012422935.
25. Santillan Salas CF, Mehra S, Pardo Crespo MR, Juhn YJ. Asthma and severity of 2009 novel H1N1 influenza: A population-based case-control study. J Asthma. 2013;50:1069-1076. https://doi.org/10.3109/02770903.2013.834505. PubMed PMID: 2013722814.
26. Harris PN, Dixit R, Francis F, et al. Pandemic influenza H1N1 2009 in north Queensland–risk factors for admission in a region with a large indigenous population. Commun Dis Intell Q Rep. 2010;34:102-109. Epub 2010/08/04 PubMed PMID: 20677419.
27. Cohen C, Moyes J, Tempia S, et al. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS ONE. 2015;10:e0118884. https://doi.org/10.1371/journal.pone.0118884. PubMed PMID: 2015869896.
28. Abdelaty NM. Risk factors and prognostic criteria in 230 patients with influenza A (H1N1) infection. Egypt J Chest Dis Tuberc. 2013;62:1-8. https://doi.org/10.1016/j.ejcdt.2013.02.006. PubMed PMID: 2013440515.
29. Allard R, Leclerc P, Tremblay C, Tannenbaum TN. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care. 2010;33:1491-1493. https://doi.org/10.2337/dc09-2215. PubMed PMID: 2010583705.
30. Balaganesakumar SR, Murhekar MV, Swamy KK, Kumar MR, Manickam P, Pandian PRT. Risk factors associated with death among influenza A (H1N1) patients, Tamil Nadu, India, 2010. J Postgrad Med. 2013;59:9-14. https://doi.org/10.4103/0022-3859.109481. PubMed PMID: 2013487239.
31. Chowell G, Ayala A, Berisha V, Viboud C, Schumacher M. Risk factors for mortality among 2009 A/H1N1 influenza hospitalizations in Maricopa County, Arizona, April 2009 to March 2010. Comput Math Methods Med. 2012;2012:914196. https://doi.org/10.1155/2012/914196. PubMed PMID: 2012475971.
32. Hanslik T, Boelle PY, Flahault A. Preliminary estimation of risk factors for admission to intensive care units and for death in patients infected with A(H1N1)2009 influenza virus, France, 2009-2010. PLoS Currents. 2010;2:RRN1150. Epub 2010/03/17. PubMed PMID: 20228857; PubMed Central PMCID: PMCPMC2836028.
33. Da Dalt L, Chillemi C, Cavicchiolo ME, et al. Pandemic influenza A (H1N1v) infection in pediatric population: a multicenter study in a North-East area of Italy. Ital J Pediatr. 2011;37:24. https://doi.org/10.1186/1824-7288-37-24. PubMed PMID: 2012258662.
34. Del Rosal T, Baquero-Artigao F, Calvo C, et al. Pandemic H1N1 influenza-associated hospitalizations in children in Madrid, Spain. Influenza Other Respir Viruses. 2011;5:e544-e551. https://doi.org/10.1111/j.1750-2659.2011.00272.x. PubMed PMID: 2011582674.
35. Gentile A, Bakir J, Russ C, et al. Study of respiratory influenza A H1N1 Virus (pH1N1) in hospitalized children in the pandemic year. Experience in 34 centers in Argentina. Arch Argent Pediatr. 2011;109:198-203. Epub 2011/06/11. https://doi.org/10.1590/s0325-00752011000300003. PubMed PMID: 21660384.
36. Kobayashi M, Ohfuji S, Fukushima W, et al. Pediatric hospitalizations with influenza A infection during the 2009-2010 pandemic in five hospitals in Japan. Pediatr Int. 2012;54:613-618. https://doi.org/10.1111/j.1442-200X.2012.03645.x.PubMedPMID:WOS:000309234600003.
37. Labeaud AD, Wentworth B, Gildengorin G, Tam K, Guardia-Labar L, Petru A. Comparison of moderate and severe hospitalized pediatric 2009 H1N1 influenza cases. Pediatr Infect Dis J. 2013;32:e90-e93. https://doi.org/10.1097/INF.0b013e31827882f9. PubMed PMID: 2013069053.
38. Myles PR, Semple MG, Lim WS, et al. Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK. Thorax. 2012;67:709-717. https://doi.org/10.1136/thoraxjnl-2011-200266. PubMed PMID: 2012423143.
39. Poeppl W, Hell M, Herkner H, et al. Clinical aspects of 2009 pandemic influenza A (H1N1) virus infection in Austria. Infection. 2011;39:341-352. https://doi.org/10.1007/s15010-011-0121-9. PubMed PMID: 2011612653.
40. Hlavinkova L, Kristufkova Z, Mikas J. Risk factors for severe outcome of cases with pandemic influenza A(H1N1)pdm09. Bratisl Lek Listy. 2015;116:389-393. PubMed PMID: 26084742.
41. Thompson DL, Jungk J, Hancock E, et al. Risk factors for 2009 pandemic influenza A (H1N1)-related hospitalization and death among racial/ethnic groups in New Mexico. Am J Public Health. 2011;101:1776-1784. https://doi.org/10.2105/AJPH.2011.300223. PubMed PMID: 21778495.
42. Garnacho-Montero J, Gutierrez-Pizarraya A, Marquez JA, et al. Epidemiology, clinical features, and prognosis of elderly adults with severe forms of influenza A (H1N1). J Am Geriatr Soc. 2013;61:350-356. https://doi.org/10.1111/jgs.12152. PubMed PMID: 2013179747.
43. Ribeiro AF, Pellini ACG, Kitagawa BY, et al. Risk factors for death from influenza A (H1N1)pdm09, State of Sao Paulo, Brazil, 2009. PLoS ONE. 2015;10:e0118772. https://doi.org/10.1371/journal.pone.0118772. PubMed PMID: 2015839093.
44. Zolotusca L, Jorgensen P, Popovici O, et al. Risk factors associated with fatal influenza, Romania, October 2009-May 2011. Influenza Other Respir Viruses. 2014;8:8-12. https://doi.org/10.1111/irv.12209. PubMed PMID: 2013812453.
45. Payet C, Lutringer-Magnin D, Cassier P, et al. Description of patients with confirmed influenza A(H1N1)pdm09 admitted to an intensive care unit and identification of severity risk factors. Med Mal Infect. 2013;43:81-84. https://doi.org/10.1016/j.medmal.2013.01.016. PubMed PMID: 2013217279.
46. Wu UI, Wang JT, Ho YC, Pan SC, Chen YC, Chang SC. Factors associated with development of complications among adults with influenza: A 3-year prospective analysis. J Formos Med Assoc. 2012;111:364-369. https://doi.org/10.1016/j.jfma.2011.04.005. PubMed PMID: 2012425846.
47. Peralta PSO, Cortes-Garcia M, Vicente-Herrero M, et al. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza A (H1N1) in Spain, April - December 2009. Euro Surveill. 2010a;15:9-17. PubMed PMID: WOS:000282643700003.
48. Gilca R, de Serres G, Boulianne N, et al. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza Other Respir Viruses. 2011;5:247-255. https://doi.org/10.1111/j.1750-2659.2011.00204.x. PubMed PMID: 2011323268.
49. Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE. 2009;4:e6051. Epub 2009/06/27. https://doi.org/10.1371/journal.pone.0006051. PubMed PMID: 19557130; PubMed Central PMCID: PMCPMC2699035.
50. Lehners N, Geis S, Eisenbach C, Neben K, Schnitzler P. Changes in severity of influenza a(H1N1)pdm09 infection from pandemic to first postpandemic season, Germany. Emerg Infect Dis. 2013;19:748-755. https://doi.org/10.3201/eid1905.120034. PubMed PMID: 2013269981.
51. Zhang PJ, Cao B, Li XL, et al. Risk factors for adult death due to 2009 pandemic influenza A(H1N1) virus infection: a 2151 severe and critical cases analysis. Chin Med J. 2013a;126:2222-2228. https://doi.org/10.3760/cma.j.issn.0366-6999.20130871. PubMed PMID: 2013391889.
52. Godoy P, Rodes A, Alvarez J, et al. Characteristics of cases hospitalized for severe pandemic (H1N1) 2009 in Catalonia. Rev Esp Salud Publica. 2011;85:81-87. PubMed PMID: 21750846.
53. Mata-Marín LA, Mata-Marín JA, Vásquez-Mota VC, et al. Risk factors associated with mortality in patients infected with influenza A/H1N1 in Mexico. BMC Res Notes. 2015;8:432. https://doi.org/10.1186/s13104-015-1349-8.PubMedPMID:PMC4566398.
54. Cheng AC, Holmes M, Senanayake S, et al. Influenza epidemiology in adults admitted to sentinel Australian hospitals in 2014: the influenza complications alert network (FLUCAN). Commun Dis Intell. 2015;39:E355-E360. PubMed PMID: WOS:000369176100006.
55. Gordon CL, Johnson PDR, Permezel M, et al. Association between Severe Pandemic 2009 Influenza A (H1N1) Virus Infection and Immunoglobulin G(2) Subclass Deficiency. Clin Infect Dis. 2010;50:672-678. https://doi.org/10.1086/650462.PubMedPMID:WOS:000274329400003.
56. World Health Organization. Child mortality Geneva, Switzerland: WHO; 2011 [cited 2017]. Available from: http://www.who.int/pmnch/media/press_materials/fs/fs_mdg4_childmortality/en/.
57. World Health Organization. Maternal mortality Geneva, Switzerland 2016 [cited 2017]. Available from: http://www.who.int/mediacentre/factsheets/fs348/en/.
58. Carstensen B, Kristensen JK, Ottosen P, Borch-Johnsen K. The Danish National Diabetes Register: trends in incidence, prevalence and mortality. Diabetologia. 2008;51:2187-2196. Epub 2008/09/26. https://doi.org/10.1007/s00125-008-1156-z. PubMed PMID: 18815769.
59. Xu J, Murphy SL, Kochanek KD, Bastian BA. Deaths: final data for 2013. Natl Vital Stat Rep. 2016;64:1-119.
60. Matias G, Taylor R, Haguinet F, Schuck-Paim C, Lustig R, Shinde V. Estimates of mortality attributable to influenza and RSV in the United States during 1997-2009 by influenza type or subtype, age, cause of death, and risk status. Influenza Other Respir Viruses. 2014;8:507-515. Epub 2014/07/01. https://doi.org/10.1111/irv.12258. PubMed PMID: 24975705; PubMed Central PMCID: PMCPMC4181813.